Abstract
The signaling pathways mediated by the transforming growth factor-β (TGF-β) family of factors are implicated in a wide array of biological processes including cell differentiation and proliferation, determination of cell fate during embryogenesis, cell adhesion and cell death. The recent discovery of the SMAD family of signal transducer proteins as mediators of TGF-β relaying signals from cell membrane to nucleus has revolutionized the understanding of the molecular basis of these processes (1,2). To date, at least eight homologues of the Smad genes have been identified and shown to be downstream of the serine/threonine kinase receptors Table 1 ). SMADs are molecules of relative mass 42K-60K composed of two regions of homology at the amino and carboxy terminals of the protein. The activation of SMADs by receptors upon TGF-β binding results in the formation of hetero-oligomeric complexes and translocation to the nucleus where transcription of target genes is effected. However, some of the SMADs apparently inhibit rather than mediate, TGF-β signaling. These inhibitory SMADs are also induced by TGF-β stimulation suggesting that there is an intracellular negative-feedback loop.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Heldin, C-H., Miyazono, K., and Dijke, P. T. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465–4171.
Massague, J. (1998) TGF-βeta signal transduction. Annu. Rev. Biochem. 67, 753–791.
Masuyama. N., Hanafusa. H., Kusakabe, M., Shibuya, H., and Nishida, E. (1999) Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J. Biol. Chem. 274, 12,163–12,170.
Hata, A., Lagna, G., Massague, J., and Hemmati-Brivanlou, A. (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186–197.
Roberts, A. B. (1998) Molecular and cell biology of TGF-β. Miner. Electrolyte Metab. 24(2-3), 111–119.
Sporn, M. B. and Roberts, A. B. 1988. Peptide growth factors are multifunctional. Nature 332, 217–219.
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian. R. K., Roberts, A. B., Sporn, M. B., and Goeddel, D. V. (1985) Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316, 701–705.
Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., and Derynck, R. (1992) Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J. Cell Biol. 118, 715–726.
Glynne-Jones, E., Harper, M. E., Goddard, L., Eaton, C. L., Matthews, P. N., and Griffiths, K. (1994) Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 25, 210–218.
Guise, T. A. and Mundy, G. R. (1998) Cancer and bone. Endocr. Rev. 19, 18–54.
Sporn, M. B. and Roberts, A. B. (1985) Autocrine growth factors and cancer. Nature 313, 745–747.
Roberts, A. B. and Sporn, M. B. (1993) Physiological actions and clinical applications of transforming growth factor-beta (TGF-βeta). Growth Factors 8, 1–9.
Kim, I. Y., Ahn, H.-J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J-.H., Kato, M., and Lee, C. (1996) Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res. 56, 44–48.
Kimchi, A., Wang, X.-F., Weinberg, R., Cheifetzn, S., and Massague, J. (1988) Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240, 196–199.
Park, K., Kim, S.-J., Bang. Y.-J., Park, J.-G., Kim, N. K., Roberts, A. B., and Sporn, M. B. (1994) Genetic changes in the transforming growth factor beta (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 91, 8772–8776.
Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Centry, L. E., Wang, X.-F., and Brattain, M. G. (1994) Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269, 26,449–26,455.
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L. Z., Lutterbaough, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. G., and Willson, J. K. V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability Science 268, 1336–1338.
Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55, 5548–5550.
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajaput, A., Thiagalingam, S., Lutterbaugh, J. D., Neumann, A., Brattain, M. G., Chang, J., Kim, S.-J., Kinzler, K. W., Vogelstein, B., Willson, J. K. V., and Markowitz, S. (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers Cancer Res. 59, 320–324.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokawa, K., Takahashi, T., and Takahashi, T. (1996) Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Cancer Res. 56, 2718–2720.
Uchida, K., Nagatake, M., Osada, H., Yatabe, Y., Kondo, M., Mitsudomi, T., Matsuda, A., Takahashi, T., and Takahashi, T. (1996) Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56, 5583–5585.
Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S., Hamilton, S. R., Kern, S. E., Kinzler, K. W., and Vogelstein, B. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genet. 13, 343–346.
Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. (1996) DPC4 gene in various tumor types. Cancer Res. 56, 2527–2530.
Riggins, J. G., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. (1997) Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578–2580.
Hahn, S. A, Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H, and Kern, S. E. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353.
Riggins, J. G., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S., Kinzler, K. W., and Vogelstein, B. (1996) MAD-related genes in the human. Nature Genet. 13, 347–349.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A., Leppert, M., Nakamura, Y., White, R., Smith, A. M. M., and Boss, J. L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525–532.
Yogota, J. and Sugimura, T. (1993) Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FESEB J. 7, 920–925.
Ueda, T., Komiya, A., Emi, M., Suzuki, H., Shiraishi, T., Yatani, R., Masai, M., Yasuda, K., and Ito, H. (1997) Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer. Genes Chromosom. Cancer 20, 140–147.
Amendt, C., Schirmacher, P., Weber, H., and Blessing, M. (1998) Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and acceleration of carcinoma development. Oncogene 17, 25–34.
Takei, K., Kohno, T., Hamada, K., Takita, J., Noguchi, M., Matsuno, Y., Hirohashi, S., Uezato, H., and Yokota, J. (1998) A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res. 58, 3700–3705.
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. (1996) MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543–552.
Jonson, T., Gorunova, L., Dawiskiba, S., Andren-Sandberg, A., Stenman, G., ten Dijke, P., Johansson, B. and M. Hoglund. (1999) Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosomes Cancer 24, 62–71.
Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N. E., Heldin, C. H., and ten Dijke, P. (1997) Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631–635.
Watanabe, T. K., Suzuki, M., Omori, Y., Hishigaki, H., Horie, M., Kanemoto, N., Fujiwara, T., Nakamura, Y., and Takahashi, E. (1997) Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 42, 446–451.
Miyaki, M, Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., Utsunomiya, J., Kuroki, T., and Mori, T. (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18, 3098–3103.
Bartsch, D., Hahn, S. A., Danichevski, K. D., Ramaswamy, A., Bastian, D., Galehdari, H., Barth, P., Schmiegel, W., Simon, B., and Rothmund, M. (1999) Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene 18, 2367–2371.
Hoque, A. T., Hahn, S. A., Schutte, M., and Kern, S. E. (1997) DPC4 gene mutation in colitis associated neoplasia. Gut 40, 120–122.
Kim, S. K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittelman, W. N., Hong, W. K., Lotan, R., and Mao, L. (1996) DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56, 2519–2521.
Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumori-genesis. Cell 61, 759–767.
Knudson, A. G. (1996) Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122, 135–140.
Powell, S. M., Peterson, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 329, 1982–1987.
Willson, J. K. V., Bittner, G. N., Oberley, T. D., Meisner, L. F., and Weese, J. L. (1987) Cell culture of human colon adenomas and carcinomas. Cancer Res. 47, 2704–2713.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Thiagalingam, S. (2001). Molecular Detection of Smad2/Smad4 Alterations in Colorectal Tumors. In: M., S. (eds) Colorectal Cancer. Methods in Molecular Medicine, vol 50. Humana Press. https://doi.org/10.1385/1-59259-084-5:149
Download citation
DOI: https://doi.org/10.1385/1-59259-084-5:149
Publisher Name: Humana Press
Print ISBN: 978-0-89603-767-0
Online ISBN: 978-1-59259-084-1
eBook Packages: Springer Protocols